Using Platelet-Rich Plasma to Treat Severe Dry Eye Syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of injecting Platelet-Rich Plasma (PRP) into the lacrimal gland to enhance tear production in patients suffering from severe dry eye syndrome due to aqueous deficiency. Participants will receive four PRP injections during the study period. The goal is to determine if this treatment can restore normal lacrimal secretion and alleviate symptoms associated with dry eye conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Platelet counts, and clotting factors in the standarts
* Presenting with severe dry keratoconjunctivitis diagnosed by an ophthalmologist

Exclusion Criteria:

* Patients with significant fibrosis of the conjunctival portion of the lacrimal gland
* Patients with complete stenosis of both lacrimal meatus in the treated eye

Where it's running

• CHU de Nice
  Nice, Site Principal Investigator, France Recruiting

Study contacts

• Study coordinator: Doctor Jean Philippe GROSSE, Dr
• Email: causeret.m@chu-nice.fr
• Phone: 04.92.03.47.02

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Lycium barbarum polysaccharide for dry eye symptoms in adults

  Adults with dry eye disease will try taking Lycium barbarum polysaccharide tablets twice daily for 12 weeks to see if their symptoms and eye tests improve and to check safety.

  Recruiting The Hong Kong Polytechnic University · Hong Kong, Hong Kong · NCT07842536

• See if rinsing the eye reduces inflammation and symptoms in severe dry eye

  This trial tests whether rinsing the surface of the eye can lower inflammation and improve symptoms for people with severe dry eye disease.

  Recruiting Rinsada · Pittsburgh, Pennsylvania · NCT07618364

• Eye drops combining an added medicinal ingredient with hyaluronic acid 0.3% versus hyaluronic acid 0.3% alone for moderate-to-severe dry eye

  We will test whether eye drops that combine an additional medicinal ingredient with hyaluronic acid 0.3% help adults with moderate-to-severe dry eye as well as or better than hyaluronic acid 0.3% alone.

  Recruiting at 2 sites FB Vision S.p.A · Cagliari, CA and 1 other locations · NCT07412860

• Comparing tear structure in menopausal and non-menopausal women

  This study is testing how menopause affects tear quality and production in women, including those on hormone therapy, to see if there are differences between pre-menopausal and post-menopausal women.

  Recruiting Chung Shan Medical University · Taichung, Taiwan · NCT06848829

• Comparing red and blue light therapy for dry eye conditions

  This study is testing whether red or blue light therapy can help people with dry eye conditions feel better and improve their eye health.

  Recruiting Aston University · Auckland and 1 other locations · NCT06371300

• Non-invasive radiofrequency treatment for dry eye disease

  This study is testing if a new non-invasive radiofrequency treatment combined with a special eye massage can help people with stubborn dry eye feel better compared to just the massage alone.

  Recruiting at 2 sites The University of Hong Kong · Hong Kong, Hong Kong and 1 other locations · NCT06220474

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.